Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

634 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Accessibility, sustainability, excellence: how to expand access to research publications. Executive summary.
Finch J, Bell S, Bellingan L, Campbell R, Donnelly P, Gardner R, Hall M, Hall S, Kiley R, van der Stelt W, Sweeney D, Sykes P, Tickell A, Wissenburg A, Egginton R, Jubb M; Working Group on Expanding Access to Published Research Findings. Finch J, et al. Among authors: sweeney d. Int Microbiol. 2013 Jun;16(2):125-32. doi: 10.2436/20.1501.01.187. Int Microbiol. 2013. PMID: 24400530 Free article. No abstract available.
Financing open-access publication after 2024.
Røttingen JA, Sweeney D. Røttingen JA, et al. Among authors: sweeney d. Nature. 2019 Aug;572(7771):586. doi: 10.1038/d41586-019-02547-y. Nature. 2019. PMID: 31455914 No abstract available.
Q&A: The numbers game.
Sweeney D, Fleming N. Sweeney D, et al. Nature. 2015 Apr 30;520(7549):S21. doi: 10.1038/520S21a. Nature. 2015. PMID: 25924195 No abstract available.
SARS-CoV-2 RNA and nucleocapsid antigen are blood biomarkers associated with severe disease outcomes that improve in response to remdesivir.
Singh K, Rubenstein K, Callier V, Shaw-Saliba K, Rupert A, Dewar R, Laverdure S, Highbarger H, Lallemand P, Huang ML, Jerome KR, Sampoleo R, Mills MG, Greninger AL, Juneja K, Porter D, Benson CA, Dempsey W, El Sahly HM, Focht C, Jilg N, Paules CI, Rapaka RR, Uyeki TM, Lane HC, Beigel J, Dodd LE; Adaptive COVID-19 Treatment Trial (ACTT-1) Study Group Members. Singh K, et al. J Infect Dis. 2024 Apr 24:jiae198. doi: 10.1093/infdis/jiae198. Online ahead of print. J Infect Dis. 2024. PMID: 38657001
Challenges for a broad international implementation of the current severe community-acquired pneumonia guidelines.
Salluh JIF, Póvoa P, Beane A, Kalil A, Sendagire C, Sweeney DA, Pilcher D, Polverino E, Tacconelli E, Estenssoro E, Frat JP, Ramirez J, Reyes LF, Roca O, Nseir S, Nobre V, Lisboa T, Martin-Loeches I. Salluh JIF, et al. Among authors: sweeney da. Intensive Care Med. 2024 Apr;50(4):526-538. doi: 10.1007/s00134-024-07381-z. Epub 2024 Mar 28. Intensive Care Med. 2024. PMID: 38546855 Review.
Rapid and sensitive detection of genome contamination at scale with FCS-GX.
Astashyn A, Tvedte ES, Sweeney D, Sapojnikov V, Bouk N, Joukov V, Mozes E, Strope PK, Sylla PM, Wagner L, Bidwell SL, Brown LC, Clark K, Davis EW, Smith-White B, Hlavina W, Pruitt KD, Schneider VA, Murphy TD. Astashyn A, et al. Among authors: sweeney d. Genome Biol. 2024 Feb 26;25(1):60. doi: 10.1186/s13059-024-03198-7. Genome Biol. 2024. PMID: 38409096 Free PMC article.
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.
Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X; CORIMUNO-19 Collaborative Group; DisCoVeRy Study Group; ACTT-2 Study Group; ACTT-3 Study Group. Siempos II, et al. EClinicalMedicine. 2024 Feb 9;69:102472. doi: 10.1016/j.eclinm.2024.102472. eCollection 2024 Mar. EClinicalMedicine. 2024. PMID: 38361992 Free PMC article.
634 results